These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 20886841)

  • 1. Phosphoproteomic analysis reveals site-specific changes in GFAP and NDRG2 phosphorylation in frontotemporal lobar degeneration.
    Herskowitz JH; Seyfried NT; Duong DM; Xia Q; Rees HD; Gearing M; Peng J; Lah JJ; Levey AI
    J Proteome Res; 2010 Dec; 9(12):6368-79. PubMed ID: 20886841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of the detergent-insoluble brain proteome in frontotemporal lobar degeneration using SILAC internal standards.
    Seyfried NT; Gozal YM; Donovan LE; Herskowitz JH; Dammer EB; Xia Q; Ku L; Chang J; Duong DM; Rees HD; Cooper DS; Glass JD; Gearing M; Tansey MG; Lah JJ; Feng Y; Levey AI; Peng J
    J Proteome Res; 2012 May; 11(5):2721-38. PubMed ID: 22416763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative phosphoproteome analysis of Streptomyces coelicolor by immobilized zirconium (IV) affinity chromatography and mass spectrometry reveals novel regulated protein phosphorylation sites and sequence motifs.
    Alonso-Fernández S; Arribas-Díez I; Fernández-García G; González-Quiñónez N; Jensen ON; Manteca A
    J Proteomics; 2022 Oct; 269():104719. PubMed ID: 36089190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis.
    Götzl JK; Mori K; Damme M; Fellerer K; Tahirovic S; Kleinberger G; Janssens J; van der Zee J; Lang CM; Kremmer E; Martin JJ; Engelborghs S; Kretzschmar HA; Arzberger T; Van Broeckhoven C; Haass C; Capell A
    Acta Neuropathol; 2014; 127(6):845-60. PubMed ID: 24619111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration.
    Yousef A; Robinson JL; Irwin DJ; Byrne MD; Kwong LK; Lee EB; Xu Y; Xie SX; Rennert L; Suh E; Van Deerlin VM; Grossman M; Lee VM; Trojanowski JQ
    Acta Neuropathol Commun; 2017 Sep; 5(1):68. PubMed ID: 28877758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U.
    Tsai KJ; Yang CH; Fang YH; Cho KH; Chien WL; Wang WT; Wu TW; Lin CP; Fu WM; Shen CK
    J Exp Med; 2010 Aug; 207(8):1661-73. PubMed ID: 20660618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Pathways Involved in Frontotemporal Lobar Degeneration with TDP-43 Proteinopathy: What Can We Learn from Proteomics?
    Mol MO; Miedema SSM; van Swieten JC; van Rooij JGJ; Dopper EGP
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration.
    Foulds PG; Davidson Y; Mishra M; Hobson DJ; Humphreys KM; Taylor M; Johnson N; Weintraub S; Akiyama H; Arai T; Hasegawa M; Bigio EH; Benson FE; Allsop D; Mann DM
    Acta Neuropathol; 2009 Nov; 118(5):647-58. PubMed ID: 19823856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological phosphorylation of tau and TDP-43 by TTBK1 and TTBK2 drives neurodegeneration.
    Taylor LM; McMillan PJ; Liachko NF; Strovas TJ; Ghetti B; Bird TD; Keene CD; Kraemer BC
    Mol Neurodegener; 2018 Feb; 13(1):7. PubMed ID: 29409526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease.
    Pottier C; Bieniek KF; Finch N; van de Vorst M; Baker M; Perkersen R; Brown P; Ravenscroft T; van Blitterswijk M; Nicholson AM; DeTure M; Knopman DS; Josephs KA; Parisi JE; Petersen RC; Boylan KB; Boeve BF; Graff-Radford NR; Veltman JA; Gilissen C; Murray ME; Dickson DW; Rademakers R
    Acta Neuropathol; 2015 Jul; 130(1):77-92. PubMed ID: 25943890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant septin 11 is associated with sporadic frontotemporal lobar degeneration.
    Gozal YM; Seyfried NT; Gearing M; Glass JD; Heilman CJ; Wuu J; Duong DM; Cheng D; Xia Q; Rees HD; Fritz JJ; Cooper DS; Peng J; Levey AI; Lah JJ
    Mol Neurodegener; 2011 Nov; 6():82. PubMed ID: 22126117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAR DNA-Binding Protein 43 and Disrupted in Schizophrenia 1 Coaggregation Disrupts Dendritic Local Translation and Mental Function in Frontotemporal Lobar Degeneration.
    Endo R; Takashima N; Nekooki-Machida Y; Komi Y; Hui KK; Takao M; Akatsu H; Murayama S; Sawa A; Tanaka M
    Biol Psychiatry; 2018 Oct; 84(7):509-521. PubMed ID: 29752072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The molecular pathology of frontotemporal lobar degeneration].
    Fujishiro H; Hasegawa M; Arai T
    Seishin Shinkeigaku Zasshi; 2010; 112(4):313-24. PubMed ID: 20496755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration.
    Ishiki A; Kamada M; Kawamura Y; Terao C; Shimoda F; Tomita N; Arai H; Furukawa K
    J Neurochem; 2016 Jan; 136(2):258-61. PubMed ID: 26485083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
    JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous quantification of protein phosphorylation sites using liquid chromatography-tandem mass spectrometry-based targeted proteomics: a linear algebra approach for isobaric phosphopeptides.
    Xu F; Yang T; Sheng Y; Zhong T; Yang M; Chen Y
    J Proteome Res; 2014 Dec; 13(12):5452-60. PubMed ID: 25403019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocytic TDP-43 pathology in Alexander disease.
    Walker AK; Daniels CM; Goldman JE; Trojanowski JQ; Lee VM; Messing A
    J Neurosci; 2014 May; 34(19):6448-58. PubMed ID: 24806671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoproteomic analysis of rat liver by high capacity IMAC and LC-MS/MS.
    Moser K; White FM
    J Proteome Res; 2006 Jan; 5(1):98-104. PubMed ID: 16396499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy.
    Arai T; Hasegawa M; Nonoka T; Kametani F; Yamashita M; Hosokawa M; Niizato K; Tsuchiya K; Kobayashi Z; Ikeda K; Yoshida M; Onaya M; Fujishiro H; Akiyama H
    Neuropathology; 2010 Apr; 30(2):170-81. PubMed ID: 20102522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration?
    Whitwell JL; Jack CR; Parisi JE; Senjem ML; Knopman DS; Boeve BF; Rademakers R; Baker M; Petersen RC; Dickson DW; Josephs KA
    Neurology; 2010 Dec; 75(24):2212-20. PubMed ID: 21172844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.